Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson consolidated total assets ($M) ($M)
Form 10-Q / 10-K Consolidated Balance Sheets & Segment Note
Latest, Q3 2026
197,425
Period ended Sep 30, 2026
Change on a year earlier
+2.4%
192,816 in Q3 2025
History
44 quarters
Since Q4 2015
Sources
38
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Consolidated total assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 197,425 | +2.4% | Form 10-Q (filed 2026-10-21) ↗ |
| Q2 2026 | Jun 28, 2026 | 201,061 | +4.0% | Form 10-Q (filed 2026-07-23) ↗ |
| Q1 2026 | Mar 29, 2026 | 200,894 | +3.7% | Form 10-Q (filed 2026-04-22) ↗ |
| Q4 2025 | Dec 28, 2025 | 199,210 | +10.6% | Form 10-Q (filed 2026-10-21) ↗ |
| Q3 2025 | Sep 28, 2025 | 192,816 | +8.1% | Form 10-Q (filed 2025-10-22) ↗ |
| Q2 2025 | Jun 29, 2025 | 193,389 | +6.8% | Form 10-Q (filed 2025-07-24) ↗ |
| Q1 2025 | Mar 30, 2025 | 193,671 | +12.6% | Form 10-Q (filed 2025-04-23) ↗ |
| Q4 2024 | Dec 29, 2024 | 180,104 | +7.5% | Form 10-K (filed 2026-02-11) ↗ |
| Q3 2024 | Sep 29, 2024 | 178,287 | +7.4% | Form 10-Q (filed 2024-10-23) ↗ |
| Q2 2024 | Jun 30, 2024 | 181,088 | -5.5% | Form 10-Q (filed 2024-07-25) ↗ |
| Q1 2024 | Mar 31, 2024 | 171,966 | -12.2% | Form 10-Q (filed 2024-05-01) ↗ |
| Q4 2023 | Dec 31, 2023 | 167,558 | -10.6% | Form 10-K (filed 2025-02-13) ↗ |
| Q3 2023 | Oct 1, 2023 | 166,061 | -5.2% | Form 10-Q (filed 2023-10-27) ↗ |
| Q2 2023 | Jul 2, 2023 | 191,686 | +7.9% | Form 10-Q (filed 2023-07-31) ↗ |
| Q1 2023 | Apr 2, 2023 | 195,969 | +9.9% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Jan 1, 2023 | 187,378 | +2.9% | Form 10-K (filed 2024-02-16) ↗ |
| Q3 2022 | Oct 2, 2022 | 175,124 | -2.3% | Form 10-Q (filed 2022-10-27) ↗ |
| Q2 2022 | Jul 3, 2022 | 177,724 | +0.7% | Form 10-Q (filed 2022-07-29) ↗ |
| Q1 2022 | Apr 3, 2022 | 178,355 | +3.4% | Form 10-Q (filed 2022-04-29) ↗ |
| Q4 2021 | Jan 2, 2022 | 182,018 | +4.1% | Form 10-K (filed 2023-02-16) ↗ |
| Q3 2021 | Oct 3, 2021 | 179,228 | +5.0% | Form 10-Q (filed 2021-10-29) ↗ |
| Q2 2021 | Jul 4, 2021 | 176,440 | +11.4% | Form 10-Q (filed 2021-07-29) ↗ |
| Q1 2021 | Apr 4, 2021 | 172,557 | +11.3% | Form 10-Q (filed 2021-04-30) ↗ |
| Q4 2020 | Jan 3, 2021 | 174,894 | +10.9% | Form 10-K (filed 2022-02-17) ↗ |
| Q3 2020 | Sep 27, 2020 | 170,693 | +9.8% | Form 10-Q (filed 2020-10-23) ↗ |
| Q2 2020 | Jun 28, 2020 | 158,380 | +2.1% | Form 10-Q (filed 2020-07-24) ↗ |
| Q1 2020 | Mar 29, 2020 | 155,017 | +3.3% | Form 10-Q (filed 2020-04-29) ↗ |
| Q4 2019 | Dec 29, 2019 | 157,728 | +3.1% | Form 10-K (filed 2021-02-22) ↗ |
| Q3 2019 | Sep 29, 2019 | 155,521 | -0.1% | Form 10-Q (filed 2019-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | 155,117 | -0.2% | Form 10-Q (filed 2019-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | 150,027 | -4.2% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 30, 2018 | 152,954 | -2.8% | Form 10-Q (filed 2019-05-01) ↗ |
| Q3 2018 | Sep 30, 2018 | 155,703 | 0.0% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jul 1, 2018 | 155,365 | +1.7% | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2018 | Apr 1, 2018 | 156,625 | +8.1% | Form 10-Q (filed 2018-05-01) ↗ |
| Q4 2017 | Dec 31, 2017 | 157,303 | +11.4% | Form 10-K (filed 2019-02-20) ↗ |
| Q3 2017 | Oct 1, 2017 | 155,658 | +10.9% | 10-Q FY2017 (XBRL) ↗ |
| Q2 2017 | Jul 2, 2017 | 152,807 | +9.3% | 10-Q FY2017 (XBRL) ↗ |
| Q1 2017 | Apr 2, 2017 | 144,918 | +6.4% | 10-Q FY2017 (XBRL) ↗ |
| Q4 2016 | Jan 1, 2017 | 141,208 | +5.8% | Form 10-K (filed 2018-02-21) ↗ |
| Q3 2016 | Oct 2, 2016 | 140,369 | – | 10-Q FY2016 (XBRL) ↗ |
| Q2 2016 | Jul 3, 2016 | 139,814 | – | 10-Q FY2016 (XBRL) ↗ |
| Q1 2016 | Apr 3, 2016 | 136,231 | – | 10-Q FY2016 (XBRL) ↗ |
| Q4 2015 | Jan 3, 2016 | 133,411 | – | 10-K FY2015 (XBRL) ↗ |
Breakdown
What makes up consolidated total assets ($m)
Cite this data
StockData. (2026). Johnson & Johnson Consolidated total assets ($M) ($M), quarterly Q4 2015–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_assets_consolidated
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.